As such, PON2 inhibition has emerged as an attractive therapeutic strategy, with studies employing RNA interference, small-molecule inhibitors, or plant-derived compounds such as C. spinosa extract demonstrating significant anti-proliferative effects, particularly in colorectal and bladder cancer models (Bacchetti et al. 2022). The gene discussed is PON2; the disease is urinary bladder carcinoma.